China’s Aviation Metropolis Invites Global Partners to Seize New Opportunities in Opening-Up

ZHENGZHOU, China, Dec. 23, 2025 (GLOBE NEWSWIRE) — In central China's Henan Province, the Zhengzhou Airport Economy Zone is capturing global investors' attention with its dynamic growth. Established in 2013 as China's first aviation economic pilot zone approved by the State Council, this area has transformed from a small airport town spanning less than 20 […]

Radware Reports Results of 2025 Annual General Meeting

(NASDAQ:RDWR), TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Radware(R) (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced the results of its Annual General Meeting of Shareholders held December 22, 2025. The Company presented four proposals for the shareholders to vote on at the meeting, of

China’s Aviation Metropolis Invites Global Partners to Seize New Opportunities in Opening-Up

China's Aviation Metropolis Invites Global Partners to Seize New Opportunities in Opening-Up GlobeNewswire December 23, 2025 ZHENGZHOU, China, Dec. 23, 2025 (GLOBE NEWSWIRE) — In central China's Henan Province, the Zhengzhou Airport Economy Zone is capturing global investors' attention with its dynamic growth. Established in 2013 as China's first aviation economic pilot zone approved by

Radware Reports Results of 2025 Annual General Meeting

Radware Reports Results of 2025 Annual General Meeting GlobeNewswire December 23, 2025 TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Radware(R) (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced the results of its Annual General Meeting of Shareholders held December 22, 2025. The Company presented four

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

(NASDAQ:DNTH), LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function Top-line results in healthy volunteers anticipated in 2H'26 Dianthus to provide update on indication prioritization in 1H'26 LBL-047 (DNTH212) has the potential to be a first-line

New Crypto Mutuum Finance (MUTM) Prepares for V1 Activation With Phase 6 Now 100% Allocated

DUBAI, United Arab Emirates, Dec. 23, 2025 (GLOBE NEWSWIRE) — Mutuum Finance is entering a new stage of its development as it prepares for the activation of its V1 protocol. The project, which operates as a DeFi crypto focused on lending and borrowing, has completed allocation for Phase 6 of its token distribution. With this

Cityflee Introduces Stainless-Steel Litter Systems Designed Specifically for Multi-Cat Households

New York, Dec. 23, 2025 (GLOBE NEWSWIRE) — Responding to the rapid growth of multi-cat households and rising consumer demand for cleaner, lower-stress pet living solutions, Cityflee has introduced a stainless-steel litter system engineered specifically for homes with multiple cats. The launch reflects a broader shift in pet home design toward non-porous, easy-clean materials that

Titan Mining Closes on First-of-Its-Kind EXIM MMIA Feasibility Financing for Domestic Graphite Project

(TSX:TI),(NYSE MKT:TII), GOUVERNEUR, N.Y., Dec. 23, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI, NYSE-A:TII), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and an emerging natural flake graphite producer (a key component of the broader rare earths and critical minerals ecosystem), is pleased to announce that its wholly owned

Who Does the Best Mommy Makeover in Bellevue?

The Best Mommy Makeover in Bellevue is done by Dr. Allegra at NW Face and Body. BELLEVUE, WA / ACCESS Newswire / December 23, 2025 / The latest statistics from ASPS report 171,064 tummy tuck procedures, underscoring how strongly this mommy makeover staple has grown in popularity across the U.S. Against the backdrop, Dr. Ludwig

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) GlobeNewswire December 23, 2025 LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell

Scroll to Top